Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BIOVIE INC.

(BIVI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société BIOVIE INC.
10/14BIOVIE : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
10/14BIOVIE INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
10/13BIOVIE : Hosting Key Opinion Leader Webinar on Neuroinflammation and Insulin Resistance an..
AQ
09/22BIOVIE : to Present at Cantor Virtual Global Healthcare Conference
AQ
09/15BioVie to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Virtual Summit
GL
08/30BIOVIE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERAT..
AQ
08/11BIOVIE : Announces Pricing of Public Offering of Common Stock (Form 8-K)
PU
08/11BIOVIE INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other ..
AQ
08/11BioVie Inc. Announces Closing of Public Offering of Common Stock
GL
08/08BioVie Inc. Announces Pricing of Public Offering of Common Stock
GL
08/06BioVie Inc. Announces Proposed Public Offering of Common Stock
GL
08/05BIOVIE INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
08/05BIOVIE : Announces First Patient Enrolled in Phase 3 Study of NE3107 in Alzheimer's Diseas..
AQ
07/27BIOVIE : Presents Data Supporting use of NE3107 in the Treatment of Alzheimer's Disease at..
AQ
07/22BIOVIE : to Present Rationale for use of NE3107 for the Treatment of Alzheimer's Disease a..
AQ
07/16Basis for BioVie's Phase 3 Clinical Trial of NE3107 in the Treatment of Alzheimer's Dis..
GL
06/29Development of BioVie's NE3107 Asset Featured by the American Diabetes Association
GL
06/28BIOVIE : Added to Russell Microcap® Index
AQ
06/25BioVie Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®
GL
06/24BIOVIE : Announces First Patient Enrolled in BIV201 Phase 2b Clinical Trial for Ascites
AQ
06/23BIOVIE : Receives FDA Guidance for Phase 3 Clinical Trial of BIV201 in HRS-AKI
AQ
06/17BioVie Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®
GL
06/11BIOVIE : Announces Closing of Acquisition of BioPharma Assets from Privately Held NeurMedi..
PU
06/11BIOVIE INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Dis..
AQ
06/11BioVie Announces Closing of Acquisition of BioPharma Assets from Privately Held NeurMed..
GL
05/17BIOVIE INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
05/12BioVie Hosting Research & Development Day
GL
05/12BIOVIE : Announces Amended Terms for Asset Acquisition from Privately Held NeurMedix (Form..
PU
05/10BIOVIE : Management's Discussion and Analysis of Financial Condition and Results of Operat..
AQ
05/10BIOVIE INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secu..
AQ
05/10BioVie Announces Amended Terms for Asset Acquisition from Privately Held NeurMedix
GL
04/29BIOVIE INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
04/28BioVie to Present at 2021 B. Riley Securities' Neuroscience Conference
GL
04/27BIOVIE INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secu..
AQ
04/27BIOVIE : Acquires Biopharma Assets from Privately Held NeurMedix
AQ
03/11BIOVIE : to Present at 31st Annual Oppenheimer Healthcare Conference
AQ
03/09BIOVIE : Commences Patient Screening in Phase 2 Clinical Trial
AQ
02/19BioVie Interview to Air on Bloomberg TV in the US on the RedChip Money Report®
GL
01/29BIOVIE : Management's Discussion and Analysis of Financial Condition and Results of Operat..
AQ
2020BIOVIE : Management's Discussion and Analysis of Financial Condition and Results of Operat..
AQ
2020BIOVIE : Interview to Air on Bloomberg International on the RedChip Money Report
AQ
2020BioVie Interview to Air on Bloomberg International on the RedChip Money Report
GL
2020BIOVIE : to Participate in B. Riley Securities Liver Disease Therapeutics Day on October 2..
AQ
2020BioVie to Participate in B. Riley Securities Liver Disease Therapeutics Day on October ..
GL
2020BIOVIE INC. : Unregistered Sale of Equity Securities (form 8-K)
AQ
2020BIOVIE : Announces Closing of Public Offering of Common Stock
AQ
2020BIOVIE : 10-k/a - management's discussion and analysis of financial condition and results ..
AQ
2020BIOVIE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERAT..
AQ
2020BIOVIE INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2020Highly Accomplished Executives Join BioVie's Board of Directors
GL
2020BioVie Advances the BIV201 Clinical Program and Prefilled Syringe
GL
2020BIOVIE : Management's Discussion and Analysis of Financial Condition and Results of Operat..
AQ
2020BIOVIE : Management's Discussion and Analysis of Financial Condition and Results of Operat..
AQ
Upcoming event on BIOVIE INC.
10/26/21